Jan 12 (Reuters) – Abbvie reached a three-year agreement with U.S. President Donald Trump’s administration to provide low prices in Medicaid through TrumpRx, and pledged $100 billion over the next decade for research and development in the U.S., the company said on Monday.
(Reporting by Ruchika Khanna in Bengaluru; Editing by Chris Reese)
